Bristol-Myers (BMY) Stock Forecast for 2023 – 2026. Sell or Buy?
Updated: December 6, 2023 (05:51)Sector: Healthcare
The share price of Bristol-Myers Squibb Company (BMY) now
50/200 Day Moving Average: $53.58 / $62.28
This figure corresponds to the Average Price over the previous 50/200 days. For Bristol-Myers stocks, the 50-day moving average is the resistance level today.
For Bristol-Myers stocks, the 200-day moving average is the resistance level today.
Are you interested in Bristol-Myers Squibb Company stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Bristol-Myers stock price in 2024, 2025, 2026, 2027, 2028. How much will one Bristol-Myers share be worth in 2024 - 2028?
When should I take profit in Bristol-Myers stock? When should I record a loss on Bristol-Myers stock? What are analysts' forecasts for Bristol-Myers stock? What is the future of Bristol-Myers stock? We forecast Bristol-Myers stock performance using neural networks based on historical data on Bristol-Myers stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Bristol-Myers stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Bristol-Myers shares. This happens once a day.
Historical and forecast chart of Bristol-Myers stock
The chart below shows the historical price of Bristol-Myers stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Bristol-Myers stock price can be found in the table below.
Long-term forecasts by years.
Bristol-Myers Squibb is an American pharmaceutical company. Develops drugs in various areas of medicine, including: oncology, HIV / acquired immunodeficiency syndrome, cardiovascular diseases, diabetes, hepatitis B and C, rheumatoid arthritis and mental disorders. The mission of the company is to discover, develop and supply innovative medicines to patients so that they can overcome serious illnesses. The mission also means that the company is working to ensure that patients have access to healthcare through public and private partners. The firm’s strategy combines the scale and resources of a large pharmaceutical corporation with the entrepreneurial spirit and agility of a successful biotech firm.
Bristol-Myers Squibb started out as two different companies – Bristol-Myers and Squibb. The Squibb Corporation was formed in 1858 in Brooklyn, New York. Founder Edward Robinson Squibb was a preeminent proponent of quality control and high purity standards within the emerging pharmaceutical industry of his day. After a failed attempt to convince the American Medical Association to accept higher frequency standards, he independently published an alternative to the US Pharmacopoeia (Squibb’s Ephemeris of Materia Medica). In 1887, Hamilton College alumni William McLaren Bristol and John Ripley Myers bought Clinton Pharmaceutical from Clinton, Oneida County, New York. After Myers’ death in 1899, Bristol changed its name to Bristol-Myers Corporation. The first nationally recognized product was Sal Hepatica, a laxative mineral salt in 1903. Its second national success was the Ipana toothpaste, from 1901 to 1960. The second national success was with Ipana toothpaste, from 1901 to 1960. Bristol-Myers and Squibb merged to form Bristol-Myers Squibb in 1989.
Bristol-Myers daily forecast for a month
Bristol-Myers Daily Price Targets
Bristol-Myers Stock Forecast 12-08-2023.
Forecast target price for 12-08-2023: $50.34.
Positive dynamics for Bristol-Myers shares will prevail with possible volatility of 1.433%.
Pessimistic target level: 49.93
Optimistic target level: 50.66
Bristol-Myers Stock Forecast 12-09-2023.
Forecast target price for 12-09-2023: $50.30.
Negative dynamics for Bristol-Myers shares will prevail with possible volatility of 0.823%.
Pessimistic target level: 50.09
Optimistic target level: 50.50
Bristol-Myers Stock Forecast 12-10-2023.
Forecast target price for 12-10-2023: $50.36.
Positive dynamics for Bristol-Myers shares will prevail with possible volatility of 1.450%.
Pessimistic target level: 49.83
Optimistic target level: 50.57
Bristol-Myers Stock Forecast 12-11-2023.
Forecast target price for 12-11-2023: $50.00.
Negative dynamics for Bristol-Myers shares will prevail with possible volatility of 1.482%.
Pessimistic target level: 49.79
Optimistic target level: 50.54
Bristol-Myers Stock Forecast 12-12-2023.
Forecast target price for 12-12-2023: $50.52.
Positive dynamics for Bristol-Myers shares will prevail with possible volatility of 0.865%.
Pessimistic target level: 50.23
Optimistic target level: 50.67
Bristol-Myers Stock Forecast 12-13-2023.
Forecast target price for 12-13-2023: $51.16.
Positive dynamics for Bristol-Myers shares will prevail with possible volatility of 1.697%.
Pessimistic target level: 50.63
Optimistic target level: 51.51
BMY (BMY) Monthly Stock Prediction for 2024
Bristol-Myers forecast for this year
Bristol-Myers Stock Prediction for Jan 2024
An uptrend is forecast for this month with an optimal target price of $51.7771. Pessimistic: $49.95. Optimistic: $52.94
Bristol-Myers Stock Prediction for Feb 2024
An uptrend is forecast for this month with an optimal target price of $52.1188. Pessimistic: $51.20. Optimistic: $53.92
Bristol-Myers Stock Prediction for Mar 2024
An downtrend is forecast for this month with an optimal target price of $51.2589. Pessimistic: $50.33. Optimistic: $53.46
Bristol-Myers Stock Prediction for Apr 2024
An uptrend is forecast for this month with an optimal target price of $51.9637. Pessimistic: $49.93. Optimistic: $53.91
Bristol-Myers Stock Prediction for May 2024
An downtrend is forecast for this month with an optimal target price of $49.7058. Pessimistic: $47.60. Optimistic: $51.05
Bristol-Myers Stock Prediction for Jun 2024
An uptrend is forecast for this month with an optimal target price of $50.0612. Pessimistic: $49.02. Optimistic: $51.22
Bristol-Myers Stock Prediction for Jul 2024
An uptrend is forecast for this month with an optimal target price of $50.1989. Pessimistic: $49.32. Optimistic: $51.36
Bristol-Myers Stock Prediction for Aug 2024
An uptrend is forecast for this month with an optimal target price of $51.4137. Pessimistic: $50.68. Optimistic: $53.42
Bristol-Myers Stock Prediction for Sep 2024
An uptrend is forecast for this month with an optimal target price of $51.442. Pessimistic: $49.57. Optimistic: $52.91
Bristol-Myers Stock Prediction for Oct 2024
An downtrend is forecast for this month with an optimal target price of $48.8956. Pessimistic: $47.28. Optimistic: $50.59
Bristol-Myers Stock Prediction for Nov 2024
An downtrend is forecast for this month with an optimal target price of $47.3896. Pessimistic: $45.54. Optimistic: $49.27
Bristol-Myers Stock Prediction for Dec 2024
An downtrend is forecast for this month with an optimal target price of $45.5912. Pessimistic: $43.79. Optimistic: $47.07
Bristol-Myers (BMY) Monthly Stock Prediction for 2025
Bristol-Myers (BMY) Monthly Stock Prediction for 2026
Bristol-Myers (BMY) Monthly Stock Prediction for 2027
Bristol-Myers (BMY) Monthly Stock Prediction for 2028
Bristol-Myers information and performance
430 E. 29TH STREET, 14 FLOOR, NEW YORK, NY, US
Market capitalization of the Bristol-Myers Squibb Company is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of BMY shares in the company outstanding by the market price of one share.
EBITDA of Bristol-Myers is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Bristol-Myers (BMY) stock dividend
Bristol-Myers last paid dividends on 10/05/2023. The next scheduled payment will be on 11/01/2023. The amount of dividends is $2.28 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.